Scarica l'app Stockscreener
17.37
0.81%
0.043
Neuropace Inc Borsa (NPCE) Ultime notizie
NeuroPace Inc patients see 62 percent median seizure reduction at six months in largest FDA-reviewed study - Traders Union
Price-Driven Insight from (NPCE) for Rule-Based Strategy - Stock Traders Daily
FDA Approves NeuroPace AI Driven Feature For Epilepsy Care - HarianBasis.co
NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant™ - Insider Monkey
NeuroPace, Inc. Actuals & Estimates (NASDAQ:NPCE) - TradingView
NeuroPace (NPCE) CMO has shares withheld to cover RSU tax bill - Stock Titan
NPCE Forecast — Price Target — Prediction for 2027 - TradingView
Neuropace Inc (NPCE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuropace Inc (NPCE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 4 Neuropace Inc For: 22 June By Investing.com - Investing.com Nigeria
[Form 4] NeuroPace Inc Insider Trading Activity - Stock Titan
NeuroPace (NPCE) director granted 789 shares as quarterly fee award - Stock Titan
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Kumar Rakhi - Moomoo
NeuroPace (NPCE) director Rakhi Kumar awarded 989 shares as quarterly retainer - Stock Titan
NeuroPace, Inc.(NasdaqGM:NPCE) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Neuropace Inc (NPCE) Institutional Confidence - TradingKey
Neuropace Inc (NPCE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Neuropace Inc (NPCE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Neuropace Inc (NPCE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Neuropace Inc (NPCE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuropace Inc (NPCE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuropace Inc (NPCE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to Trade - MSN
(NPCE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
NeuroPace (NPCE) down 0.6% since last earnings report: Can it rebound? - MSN
NeuroPace Inc RNS System gains favor for targeted seizure interruption - Traders Union
Here's why you should add NeuroPace stock to your portfolio now - MSN
NPCE Explains How NeuroPace's RNS System Makes Money - MSN
NeuroPace Stock Draws Focus As RNS Adoption Expands - Kalkine Media
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now - Yahoo Finance
NeuroPace, Inc. Files Form 8-K Reporting 2026 Annual Meeting Results and Company Information - Minichart
NeuroPace shareholders elect directors and ratify auditor at annual meeting By Investing.com - Investing.com South Africa
NeuroPace shareholders elect directors and ratify auditor at annual meeting - Investing.com
NeuroPace Shareholders Approve Directors and Auditor at Meeting - TipRanks
NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting - Stock Titan
NeuroPace Inc launches webinar on RNS System for personalized epilepsy seizure prevention - Traders Union
(NPCE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NeuroPace (NPCE) director receives new stock grant and options - Stock Titan
NeuroPace (NPCE) director Fischer receives stock and option awards - Stock Titan
NeuroPace (NPCE) director Uri Geiger receives new share and option grants - Stock Titan
NeuroPace (NPCE) director receives stock grant and 5,368-share option award - Stock Titan
NeuroPace (NPCE) director receives new stock and option grants as compensation - Stock Titan
NeuroPace (NASDAQ: NPCE) director receives new stock and option grants - Stock Titan
NeuroPace (NPCE) CEO Becker has RSU tax withholding of 1,255 shares - Stock Titan
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):